Thomas Reiser/LinkedIn
Dec 11, 2025, 23:36
Register for the ISTH Andexanet Research Recap
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), posted on LinkedIn:
”How do researchers evaluate the effects of andexanet in healthy volunteers and patients with acute major bleeding on enoxaparin?
Register for the upcoming International Society on Thrombosis and Haemostasis (ISTH) RPTH Journal Research Recap on
December 18 (17:00 UTC) with author Thijs van Haaps and Moderator Lara Roberts.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease